Why Swedencare stock moves
Swedencare rose clearly without a company-news explanation.
Written after the close on ·
Why today
16,415 news analyzed todaySwedencare rose clearly without a company-news explanation.
Over the last five trading days the shares rose slightly while the market was roughly flat.
Trading was about three times a normal day's volume, and the shares sit near their one-year low after a long fall from early January.
Today's move of +1.47% was 1.5 times a normal day's 1.0%. OMX Stockholm 30 moved −1.01% on the same day.
Swedencare +1.47%OMX Stockholm 30 −1.01%Against the market
What analysts expect, and how often they have been right
Analysts’ estimates for Swedencare.
Swedencare earned more than expected in 2 out of 8 reports.
For comparison, about 46% of reports from Nordic companies beat the estimate in the last three years.
The share moved in the same direction as the earnings surprise in 7 out of 8 reports with a measured move, against about 63% of reports from Nordic companies.
Ratings
Price targets
Latest price 19.28 SEK
Earnings against expectations, and the share’s reaction
Expected EPSAbove estimateBelow estimateAs expectedSEK
Next reported quarter: expected earnings per share of 0.31 SEK (February 11). For the current fiscal year, expected earnings per share changed from 0.94 SEK three months ago to 0.73 SEK now. 2026 estimate: 0.73 SEK. 2027 estimate: 1.35 SEK. People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor. October 21: Buy about 34 thousand SEK. October 21: Buy about 295 thousand SEK. September 4: Buy about 28 thousand SEK. August 3: Buy about 64 thousand SEK. July 30: Buy about 278 thousand SEK.
Has the share price followed the business?
Price and earnings moved in the same direction: 1 out of 3 years. Across Nordic companies, that happens in about 60% of years. In 2025, the price changed −20% and earnings per share −44%.
Revenue, profit and market cap
RevenueProfitMarket capHatched bars: analysts’ estimates.bn SEK
Assets, liabilities and market cap
AssetsLiabilitiesMarket capbn SEK
Price and earnings moved in the same direction: 1 out of 3 years.Market cap (Now): 3.1 bn SEKRevenue 2025: 2.7 bn SEK
What the key figures say about Swedencare
The figures connect what Swedencare earns with what investors pay.
The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: 0.35 SEK–0.62 SEK. Peers: Humble Group -1.03 SEK, Zinzino 11.01 SEK, Atria 1.63 EUR. 2026 estimate: 0.73 SEK (0.73 SEK–0.73 SEK). 2027 estimate: 1.35 SEK (1.32 SEK–1.38 SEK).
What the company sold during the year.
2022–2025: 1.8 bn SEK–2.7 bn SEK. Peers: Humble Group 8.3 bn SEK, Zinzino 3.7 bn SEK, Atria 1.9 bn EUR. 2026 estimate: 2.8 bn SEK (2.8 bn SEK–2.8 bn SEK). 2027 estimate: 3.1 bn SEK (3.0 bn SEK–3.1 bn SEK).
The percentage of revenue left after the costs of running the business.
2022–2025: 5.1%–8.8%. Peers: Humble Group 4.1%, Zinzino 14.6%, Atria 3.6%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: 0.8%–1.3%. Peers: Humble Group −9.7%, Zinzino 55.5%, Atria 10.7%.
The price investors pay for each unit of annual earnings per share. Not shown for a loss.
2022–2025: 50.4–164.8. Peers: Zinzino 10.3, Atria 9.9. 2026 estimate: 26.4. 2027 estimate: 14.3.
What investors pay for each unit the company sells.
2022–2025: 2.29–4.14. Peers: Humble Group 0.32, Zinzino 1.22, Atria 0.24. 2026 estimate: 1.09. 2027 estimate: 1.00.
Money paid to shareholders per share, summed by calendar year.
2020–2025: 0.14 SEK–0.25 SEK.
The ordinary yearly dividend as a percentage of the share price.
2022–2025: 0.4%–0.7%. Peers: Humble Group 0.0%, Zinzino 5.3%, Atria 4.7%.
Net debt divided by operating earnings before depreciation and amortisation.
2022–2025: 2.34–4.26. Peers: Humble Group 3.73, Zinzino -1.40, Atria 2.20.
More key figures
Market cap divided by shareholders’ equity, what remains after liabilities.
2022–2025: 0.65–1.34. Peers: Humble Group 0.58, Zinzino 4.12, Atria 0.99.
Market cap plus net debt, divided by operating earnings. This includes debt.
2022–2025: 38.4–63.6.
Cash left after investments, divided by the number of shares.
2022–2025: 1.17 SEK–2.57 SEK. Peers: Humble Group 0.59 SEK, Zinzino 17.79 SEK, Atria 0.78 EUR.
The percentage of assets financed by shareholders’ equity.
2022–2025: 70.1%–77.9%.
The dividend explained
A dividend is money paid to shareholders. Swedencare paid 0.28 SEK per share in the twelve months through November 6, 2026.
On the ex-dividend day, April 24, 2026, Swedencare traded without the right to the 0.28 SEK dividend. The price went from 26.90 SEK to 26.85 SEK; including the dividend, the day's change was +0.9%. Entitlement passes from the company to shareholders on the ex-day; payment comes later.
2020: 0.14 SEK2021: 0.16 SEK2022: 0.20 SEK2023: 0.22 SEK2024: 0.23 SEK2025: 0.25 SEK2026 so far: 0.28 SEK
What to watch next, and why
The earnings report shows how Swedencare's revenue and profit have changed.
- Earnings report
The earnings report shows how Swedencare's revenue and profit have changed.
Add to calendar
More about Swedencare
Insider trades
People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor.
- Laszlo Janos Varga, senior executiveBuyabout 34 thousand SEK
- Lars Håkan Lagerberg, CEOBuyabout 295 thousand SEK
- Laszlo Janos Varga, senior executiveBuyabout 28 thousand SEK
- Laszlo Janos Varga, senior executiveBuyabout 64 thousand SEK
- Lars Håkan Lagerberg, CEOBuyabout 278 thousand SEK
Earnings report
Next report: · Add to calendar · Google Calendar
On its last 15 report days Swedencare usually moved about 8.4%. On a normal day it moves 1.0%.
−20.17% Why? −13.93% −2.36% +7.38%
10,000 SEK in Swedencare bought on November 7, 2016 is worth 38,700 SEK today, with dividends reinvested.
What would 10,000 SEK in Swedencare be worth today? →
What would 10,000 SEK in Swedencare be worth today?
38,700 SEK
with dividends reinvested, bought on November 7, 2016.
At worst it was worth 8,880 SEK (April 13, 2017).
The five biggest days of the journey
· +31.2% · the whole market rose 1.1% the same day
· −28.6% · the whole market fell 0.2% the same day
· +25.2% · the whole market was unchanged the same day · report day
· +25.1% · the whole market rose 0.4% the same day
· −24.5% · the whole market rose 1.6% the same day
Earlier days
+1.47% market −0.11% Swedencare rose slightly over the week while the broader market was roughly flat. Read →
Swedencare rose slightly over the week while the broader market was roughly flat.
The last session saw a clear rise against a clear market fall, on heavy trading.
The main company news was Kristy Murphy being named interim CEO of NaturVet on Wednesday 4 November, after Geoff Granger stepped down.
Short positions also fell over the period, which can ease pressure on a stock.
+0.00% market −0.32% Swedencare was roughly unchanged without a company-news explanation. Read →
Swedencare was roughly unchanged without a company-news explanation.
In the last session, Swedencare moved less than OMX Stockholm 30, which fell slightly.
The move was an ordinary size for Swedencare, within its usual daily range.
Over the last five trading days, Swedencare was roughly unchanged while the market rose slightly.
The share trades near its lowest close of the past year, well below its highest from early January.
−0.31% market +0.83% Swedencare was roughly unchanged, a move within its usual daily range. Read →
Swedencare was roughly unchanged, a move within its usual daily range.
The market rose clearly over the same day, so Swedencare lagged it.
Swedencare named Kristy Murphy interim CEO of NaturVet, after Geoff Granger left the role with immediate effect.
Over the last five trading days the shares were roughly unchanged, while OMX Stockholm 30 rose slightly.
Her appointment is a leadership change, not a new sales or profit figure, so it is unlikely to have moved the share price much.
−3.55% market +3.01% Swedencare fell clearly over the week while the OMX Stockholm 30 index rose clearly, so it moved against the market. Read →
Swedencare fell clearly over the week while the OMX Stockholm 30 index rose clearly, so it moved against the market.
The main driver was its third-quarter report on 21 October, where growth and profit fell short of expectations and the company lowered its full-year growth ambition.
Several analysts then cut their price targets, the share price they see as fair, on 22 October, which likely kept pressure on the shares.
Over the same days, peer stocks in the sector rose, so the sector did not explain the fall.
−2.54% market +1.57% Swedencare fell, moving against a rising market as company news explains it. Read →
Swedencare fell, moving against a rising market as company news explains it.
Its share price fell hard over the last five trading days, a very big move for this stock.
The most likely reason is the Q3 2026 earnings call, where organic growth was only 2%, a weak result that also raised doubts about the full-year growth target.
Analysts cut their price targets after the report, adding to the pressure.
Watch the next earnings report on Thursday 11 February 2027.
+2.28% market +0.41% Swedencare rose clearly, with no company news explaining the move. Read →
Swedencare rose clearly, with no company news explaining the move.
Over the same session, OMX Stockholm 30 rose slightly, so Swedencare moved more than the market.
Over the last five trading days, Swedencare fell very sharply, while OMX Stockholm 30 fell sharply, a very big move for the stock.
The main drag was the weak Q3 2026 report, which missed expectations, and several brokers cutting their price targets, the share prices they see as fair value.
Next, watch the earnings report on Thursday 11 February 2027.
−16.53% market −3.67% Swedencare fell very sharply over the last five trading days, clearly more than the broader OMX Stockholm 30 index. Read →
Swedencare fell very sharply over the last five trading days, clearly more than the broader OMX Stockholm 30 index.
The drop was very big for the stock, rare in the past year.
It followed weaker third-quarter results, with revenue growth slowing and profit below expectations.
Several analysts cut their target prices, the share prices they see as fair, and kept their ratings.
+2.45% market −2.51% Swedencare rose sharply, against a falling market. Read →
Swedencare rose sharply, against a falling market.
Company news from that day explains the rise only partly: several analysts cut their target prices, the share price they see as fair, and Qube Research & Technologies stopped being a public short seller.
Over the last five trading days the shares fell very sharply, a very big move for Swedencare, and the Stockholm index OMX Stockholm 30 fell clearly as well.
Earnings from yesterday's quarterly report missed expectations, and the company lowered its full-year growth ambition, which likely weighed on the shares.
Next, watch the full-year report due on 11 February 2027.
−20.17% market +0.17% Swedencare fell sharply after its Q3 report missed expectations. Read →
Swedencare fell sharply after its Q3 report missed expectations.
Against the market, OMX Stockholm 30 was roughly flat, so Swedencare's drop was company-specific.
Revenue rose only 3%, and operational EBITDA (core operating profit before depreciation) fell 3%, below the expected 162 million SEK.
The company also lowered its full-year growth ambition, which likely drove the sell-off.
Over the last five trading days Swedencare fell very sharply, far more than the market's slight decline, a very big move for the stock.
Learn more · Why do stocks go up and down?